2:08 PM
 | 
Dec 01, 2017
 |  BC Week In Review  |  Company News  |  Deals

Synpromics, UCL to develop gene therapy for PD

Synpromics Ltd. (Edinburgh, U.K.) partnered with University College London to generate synthetic CNS gene promoters and develop a gene therapy for Parkinson's disease.

Synpromics Founder and CSO Michael Roberts told BioCentury that the company...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >